medigraphic.com
SPANISH

Alergia, Asma e Inmunología Pediátricas

Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 2

<< Back

Alerg Asma Inmunol Pediatr 2020; 29 (2)

Atypical eye manifestation in macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

García-Domínguez M, González-López E, Arce-Cabrera D, Heras-Salazar R
Full text How to cite this article 10.35366/95492

DOI

DOI: 10.35366/95492
URL: https://dx.doi.org/10.35366/95492

Language: Spanish
References: 17
Page: 66-70
PDF size: 256.34 Kb.


Key words:

Macrophage activation syndrome, hemophagocytic lymphohistiocytosis, systemic juvenile idiopathic arthritis, choroiditis, retinitis.

ABSTRACT

Macrophage activation syndrome complicating systemic-onset juvenile idiopathic arthritis is a serious and potentially life-threatening condition. Characterized of acute hyperinflammation with fever, cytopenias, multiple organ dysfunction, and hemophagocytosis in the reticuloendothelial system with increased macrophage activity. We present adolescent of a 13-year-old with systemic-onset juvenile idiopathic arthritis complicated by macrophage activation syndrome, who developed bilateral infiltrative retinochoroiditis with an ischemic vascular component and severe vision impairment.


REFERENCES

  1. Cron RQ, Davi S, Minoia F, Ravelli A. Clinical features and correct diagnosis of macrophage activation syndrome. Expert Rev Clin Immunol. 2015; 11 (9): 1043-1053. doi: 10.1586/1744666x.2015.1058159.

  2. Bracaglia C, Prencipe G, De Benedetti F. Macrophage activation syndrome: different mechanisms leading to a one clinical syndrome. Pediatr Rheumatol Online J. 2017; 15 (1): 5. doi: 10.1186/s12969-016-0130-4.

  3. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev. 2004; 3 (2): 69-75. doi: 10.1016/S1568-9972(03)00091-0.

  4. Henter JI, Horne A, Aricó M et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007; 48 (2): 124-131. doi: 10.1002/pbc.21039.

  5. Shabbir M, Lucas J, Lazarchick J, Shirai K. Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature. Hematol Oncol. 2011; 29 (2): 100-106. doi: 10.1002/hon.960.

  6. Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun. 2012; 13 (4): 289-298. doi: 10.1038/gene.2012.3.

  7. Petty RE, Southwood TR, Manners P et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004; 31 (2): 390-392.

  8. Ravelli A, Minoia F, Davì S et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2016; 68 (3): 566-576. doi: 10.1002/art.39332.

  9. Stéphan JL, Koné-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford). 2001; 40 (11): 1285-1292. doi: 10.1093/rheumatology/40.11.1285.

  10. Zeng HS, Xiong XY, Wei YD, Wang HW, Luo XP. Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis. World J Pediatr. 2008; 4 (2): 97-101. doi: 10.1007/s12519-008-0018-6.

  11. Dubuc CE, Cáceres VA, Ecenarro MU et al. Síndrome de activación macrofágica secundario a enfermedades autoinmunes, hematológicas, infecciosas y oncológicas. Serie de 13 casos clínicos y una revisión bibliográfica. Reumatol Clin. 2015; 11 (3): 139-143. doi: 10.1016/j.reuma.2014.06.007.

  12. Chylack LT Jr, Bienfang DC, Bellows AR, Stillman JS. Ocular manifestations of juvenile rheumatoid arthritis. Am J Ophthalmol. 1975; 79 (6): 1026-1033. doi: 10.1016/0002-9394(75)90689-3.

  13. Abdwani R. Challenges of childhood uveitis. Sultan Qaboos Univ Med J. 2009; 9 (3): 247-256.

  14. Castagna I, Roszkowska AM, Alessandrello F et al. Juvenile idiopathic arthritis-associated uveitis: a retrospective analysis from a centre of South Italy. Int Ophthalmol. 2020; 40 (2): 335-342. doi: 10.1007/s10792-019-01184-8.

  15. Suhr KS, Chiang MF, Flynn JT, Engelbert M. Ocular involvement in hemophagocytic syndrome: a novel funduscopic manifestation and review of the literature. Retin Cases Brief Rep. 2016; 10 (4): 345-348. doi: 10.1097/ICB.0000000000000255.

  16. Vizcaino MA, Eberhart CG, Rodriguez FJ. Hemophagocytic lymphohistiocytosis in adults with intraocular involvement: clinicopathologic features of 3 cases. Ocul Oncol Pathol. 2017; 4 (1): 1-11. doi: 10.1159/000475551.

  17. Ruscitti P, Rago C, Breda L et al. Macrophage activation syndrome in Still’s disease: analysis of clinical characteristics and survival in paediatric and adult patients. Clin Rheumatol. 2017; 36 (12): 2839-2845. doi: 10.1007/s10067-017-3830-3.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Alerg Asma Inmunol Pediatr. 2020;29